Tec Kinases ltk and RlK in Mast Cell Signaling
Tec Kinases ltk and RlK in Mast Cell Signaling
批准号:
7098577
负责人:
LESLIE JOAN BERG
金额:
$40.58万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-01 至 2010-02-28
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Allergic asthma is a complex disease involving a localized inflammatory response mediated by lymphocytes, eosinophils and mast cells. One critical component of this response is the T helper type 2 (Th2) cytokines, including IL-4, IL-5, IL-9, and IL-13, produced by T cells and mast cells. The Tec family tyrosine kinases, Itk and Rlk, play important roles in activating phospholipase C-?1 downstream of the T cell receptor. Itk/Rlk deficient T cells show impaired TCR signaling, leading to substantially reduced cytokine production and defects in clearing pathogenic infections. Interestingly, unimmunized Itk-/- and Itk-/-Rlk-/- mice exhibit abnormalities suggestive of excess Th2-type cytokine production, such as germinal center hyperplasia in the spleen, eosinophilia, and elevated levels of serum IgE antibodies. These data, together with the fact that Itk and Rlk are also expressed in mast cells, suggest the following hypothesis: Itk and/or Rlk may be critical in T cells for IL-4 production leading to Th2 cell differentiation and cytokine production, but may also play a role in mast cell cytokine production. To test this hypothesis, we propose to determine whether the abnormalities seen in unimmunized Itk-/- and Itk-/-Rlk-/- mice are due to a T cell-intrinsic defect, a defect in mast cells, or both. Second, we find that Itk-/- bone marrow-derived mast cells secrete enhanced levels of IL-4, IL-6, and IL-13 following FceRI stimulation. Based on these data, we hypothesize that Itk is required for optimal activation of the SHIP1/Dok-1 pathway, known to attenuate mast cell responses. To test this idea, we will examine Itk-/- mast cells for alterations in degranulation and cytokine production in response to stimulation with IgE alone, IgE plus antigen, SCF, as well as to FceRI and Fc?RII co-aggregation. Biochemical analyses will directly address the role of Itk in the SHIP1-dependent pathway. The overall goal of these studies is to further our understanding of signaling pathways that may contribute to the development of allergic diseases, and to suggest mechanisms for the manipulation and/or prevention of allergic responses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TCR signaling control of thymic Treg selection and immune homeostasis
-
批准号:10531600
-
项目类别:
-
资助金额:$57.71万
-
财政年份:2019
-
负责人:LESLIE JOAN BERG
-
依托单位:
TCR signaling control of thymic Treg selection and immune homeostasis
-
批准号:10307579
-
项目类别:
-
资助金额:$57.89万
-
财政年份:2019
-
负责人:LESLIE JOAN BERG
-
依托单位:
TCR signaling control of thymic Treg selection and immune homeostasis
-
批准号:10064991
-
项目类别:
-
资助金额:$58.04万
-
财政年份:2019
-
负责人:LESLIE JOAN BERG
-
依托单位:
TCR signaling control of thymic Treg selection and immune homeostasis
-
批准号:9887472
-
项目类别:
-
资助金额:$59.89万
-
财政年份:2019
-
负责人:LESLIE JOAN BERG
-
依托单位:
Dissecting the pathways controlling tunable responses to TCR signaling
-
批准号:10074912
-
项目类别:
-
资助金额:$2.99万
-
财政年份:2018
-
负责人:LESLIE JOAN BERG
-
依托单位:
Dissecting the pathways controlling tunable responses to TCR signaling
-
批准号:10314045
-
项目类别:
-
资助金额:$47.89万
-
财政年份:2018
-
负责人:LESLIE JOAN BERG
-
依托单位:
Plasticity of T helper cell differentiation
-
批准号:8498675
-
项目类别:
-
资助金额:$39.11万
-
财政年份:2013
-
负责人:LESLIE JOAN BERG
-
依托单位:
Plasticity of T helper cell differentiation
-
批准号:8664794
-
项目类别:
-
资助金额:$41.83万
-
财政年份:2013
-
负责人:LESLIE JOAN BERG
-
依托单位:
Plasticity of T helper cell differentiation
-
批准号:8833242
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2013
-
负责人:LESLIE JOAN BERG
-
依托单位:
Regulation of conventional versus innate CD8+ T cell development
-
批准号:8317595
-
项目类别:
-
资助金额:$40.71万
-
财政年份:2011
-
负责人:LESLIE JOAN BERG
-
依托单位:
Regulation of conventional versus innate CD8+ T cell development
-
批准号:8190000
-
项目类别:
-
资助金额:$40.71万
-
财政年份:2011
-
负责人:LESLIE JOAN BERG
-
依托单位:
Regulation of conventional versus innate CD8+ T cell development
-
批准号:8516976
-
项目类别:
-
资助金额:$38.27万
-
财政年份:2011
-
负责人:LESLIE JOAN BERG
-
依托单位:
FASEB SRC on Signal Transduction in the Immune System
-
批准号:8129134
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2011
-
负责人:LESLIE JOAN BERG
-
依托单位:
ITK: an emerging target for treatment of T cell-mediated autoimmune disease
-
批准号:8386936
-
项目类别:
-
资助金额:$53.33万
-
财政年份:2010
-
负责人:LESLIE JOAN BERG
-
依托单位:
ITK: an emerging target for treatment of T cell-mediated autoimmune disease
-
批准号:8204398
-
项目类别:
-
资助金额:$56.73万
-
财政年份:2010
-
负责人:LESLIE JOAN BERG
-
依托单位:
Regulation of conventional versus innate CD8+ T cell development
-
批准号:8041181
-
项目类别:
-
资助金额:$41.13万
-
财政年份:2010
-
负责人:LESLIE JOAN BERG
-
依托单位:
ITK: an emerging target for treatment of T cell-mediated autoimmune disease
-
批准号:8581295
-
项目类别:
-
资助金额:$56.73万
-
财政年份:2010
-
负责人:LESLIE JOAN BERG
-
依托单位:
ITK: an emerging target for treatment of T cell-mediated autoimmune disease
-
批准号:8042232
-
项目类别:
-
资助金额:$56.75万
-
财政年份:2010
-
负责人:LESLIE JOAN BERG
-
依托单位:
Tec Kinases ltk and RlK in Mast Cell Signaling
-
批准号:7371047
-
项目类别:
-
资助金额:$38.7万
-
财政年份:2006
-
负责人:LESLIE JOAN BERG
-
依托单位:
Tec Kinases ltk and RlK in Mast Cell Signaling
-
批准号:7584041
-
项目类别:
-
资助金额:$38.7万
-
财政年份:2006
-
负责人:LESLIE JOAN BERG
-
依托单位:
国内基金
海外基金
基于CRF-Mast cell信号通路探索疏肝健脾法治疗IBS内脏高敏感的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:杨小军
-
依托单位: